BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15264277)

  • 1. Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer.
    Edelmann L; Edelmann W
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):91-9. PubMed ID: 15264277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models for colorectal cancer.
    Heyer J; Yang K; Lipkin M; Edelmann W; Kucherlapati R
    Oncogene; 1999 Sep; 18(38):5325-33. PubMed ID: 10498885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of DNA mismatch repair missense mutations in murine models and their impact on cancer predisposition.
    Scherer SJ; Avdievich E; Edelmann W
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):689-93. PubMed ID: 16042575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of hereditary colon cancer.
    Rustgi AK
    Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to colorectal cancer.
    de la Chapelle A
    Nat Rev Cancer; 2004 Oct; 4(10):769-80. PubMed ID: 15510158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models for hereditary nonpolyposis colorectal cancer.
    de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
    Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of HNPCC-related missense mutations in MSH2.
    Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
    Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of early-onset familial/hereditary colon cancer: new models and mechanistic biomarkers (review).
    Telang NT; Li G; Katdare M
    Int J Oncol; 2006 Jun; 28(6):1523-9. PubMed ID: 16685453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editing DNA replication and recombination by mismatch repair: from bacterial genetics to mechanisms of predisposition to cancer in humans.
    Radman M; Matic I; Halliday JA; Taddei F
    Philos Trans R Soc Lond B Biol Sci; 1995 Jan; 347(1319):97-103. PubMed ID: 7746861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mismatch repair protein].
    Ikejima M; Shimada T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1392-400. PubMed ID: 9309131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle.
    Durno CA; Gallinger S
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):5-15. PubMed ID: 16819371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.
    Hemminki A; Peltomäki P; Mecklin JP; Järvinen H; Salovaara R; Nyström-Lahti M; de la Chapelle A; Aaltonen LA
    Nat Genet; 1994 Dec; 8(4):405-10. PubMed ID: 7894494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
    Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
    Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.
    Laken SJ; Petersen GM; Gruber SB; Oddoux C; Ostrer H; Giardiello FM; Hamilton SR; Hampel H; Markowitz A; Klimstra D; Jhanwar S; Winawer S; Offit K; Luce MC; Kinzler KW; Vogelstein B
    Nat Genet; 1997 Sep; 17(1):79-83. PubMed ID: 9288102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of HNPCC: application to diagnosis and screening.
    Abdel-Rahman WM; Mecklin JP; Peltomäki P
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):208-20. PubMed ID: 16434208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).
    Lynch HT; Lynch JF; Lynch PM
    J Natl Cancer Inst; 2007 Feb; 99(4):261-3. PubMed ID: 17312298
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recognising hereditary non-polyposis colorectal cancer without a clear family history].
    de Bruin JH; Nagengast FM; Ligtenberg MJ; van Krieken JH; Niermeijer MF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2053-7. PubMed ID: 15532325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple and complex genetics of colorectal cancer susceptibility.
    Baglioni S; Genuardi M
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):35-43. PubMed ID: 15264271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.